StockCall.com Provides Stock Research on Becton, Dickinson and Co., MAKO Surgical Corp., Repros Therapeutics Inc., and Align Technology Inc.
New York City, New York -- (June 12, 2013)
One of the most of controversial features of President Obama’s Affordable Care Act (ACA) is the 2.3% tax on U.S. gross sales of medical devices. While the ACA has been generally been welcomed by the U.S. healthcare sector, medical device makers have opposed the 2.3% tax, saying that it will lead to higher costs for them and hurt innovation. The tax went into effect at the start of this year. On Tuesday, June 11, 2013, the healthcare sector ended sharply lower, tracking losses in the broader market, which tumbled after the Bank of Japan (BOJ) released its monetary policy statement. The major movers in the sector included Becton, Dickinson and Co. (NYSE: BDX), MAKO Surgical Corp. (NASDAQ: MAKO), Repros Therapeutics Inc. (NASDAQ: RPRX), and Align Technology Inc. (NASDAQ: ALGN). StockCall has taken an interest in these companies and you can now sign up to download the free technical research on BDX, MAKO, RPRX, and ALGN at
www.stockcall.com/registration
Shares in Becton Dickinson and Co. ended 0.21% lower on Tuesday at $98.31 after trading between $97.21 and $99. It also saw total volume of 670,034 shares traded after yesterday’s close, which is well below the daily average volume of 1.01 million. So far this year, the company’s shares have grown over 27%, thus outperforming the S&P 500. However, despite the gains, the stock is still trading 3.81% below its 52-week high. Shares of BDX are currently facing stiff resistance at around $102. Sign up today to read the free research report on BDX at
www.StockCall.com/BDX061213.pdf
MAKO Surgical Corp.’s stock fell sharply yesterday, reversing some of its gains from previous trading sessions. The company’s shares hit an intraday low of $11.86 before finishing the day 2.29% lower at $11.96. A total of 369,399 shares were traded which is well below the daily average volume of 1.01 million. However, despite the sharp decline, shares of MAKO have jumped 3.10% in the last three sessions. Since the beginning of this year, the stock has fallen nearly 7%, thus underperforming the S&P 500. It is currently trading 56% below its 52-week high. Register to download the free technical analysis on MAKO at
www.StockCall.com/MAKO061213.pdf
Shares in Repros Therapeutics Inc. moved higher on Tuesday, extending their gains from its previous sessions. The company’s shares ended the day 1.89% higher at $18.37 after trading between $17.65 and $18.50. A total of 187,351 shares were traded, which is less than half of the daily average volume of 389,924. Shares of RPRX have grown over 9.60% in the last three sessions. So far this year, the stock has gained over 16.60%, hence outperforming the S&P 500. Repros’ shares have moved above their 50-day moving average as a result of the recent gains. Free report on RPRX can be accessed by registering at
www.StockCall.com/RPRX061213.pdf
Align Technology Inc.’s stock was one of the worst performers in the healthcare sector on Tuesday. The company’s shares hit an intraday low of $34.35 before finishing the day 1.47% lower at $34.77. A total of 493,682 shares were traded which is well below the daily average volume of 977,319. Shares of ALGN have fallen over 2.70% in the last three sessions. However, despite the recent losses, the stock is still up 25.30% so far this year.Register withStockCall and download the research on ALGN for free at
www.StockCall.com/ALGN061213.pdf
About StockCall.com
StockCall.com is a financial website where investors can have easy, precise and comprehensive research and opinions on stocks making the headlines. Sign up today to talk to our financial analyst at
www.stockcall.com
Contact Person:
William T. Knight
Email: info@stockcall.com
Contact Number: (646) 396-9857 (9:00 am EST – 01:30 pm EST)